Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Braz. j. med. biol. res ; 42(9): 824-830, Sept. 2009. ilus, graf
Article in English | LILACS | ID: lil-524318

ABSTRACT

The generation of bradykinin (BK; Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) in blood and kallidin (Lys-BK) in tissues by the action of the kallikrein-kinin system has received little attention in non-mammalian vertebrates. In mammals, kallidin can be generated by the coronary endothelium and myocytes in response to ischemia, mediating cardioprotective events. The plasma of birds lacks two key components of the kallikrein-kinin system: the low molecular weight kininogen and a prekallikrein activator analogous to mammalian factor XII, but treatment with bovine plasma kallikrein generates ornitho-kinin [Thr6,Leu8]-BK. The possible cardioprotective effect of ornitho-kinin infusion was investigated in an anesthetized, open-chest chicken model of acute coronary occlusion. A branch of the left main coronary artery was reversibly ligated to produce ischemia followed by reperfusion, after which the degree of myocardial necrosis (infarct size as a percent of area at risk) was assessed by tetrazolium staining. The iv injection of a low dose of ornitho-kinin (4 µg/kg) reduced mean arterial pressure from 88 ± 12 to 42 ± 7 mmHg and increased heart rate from 335 ± 38 to 402 ± 45 bpm (N = 5). The size of the infarct was reduced by pretreatment with ornitho-kinin (500 µg/kg infused over a period of 5 min) from 35 ± 3 to 10 ± 2 percent of the area at risk. These results suggest that the physiological role of the kallikrein-kinin system is preserved in this animal model in spite of the absence of two key components, i.e., low molecular weight kininogen and factor XII.


Subject(s)
Animals , Bradykinin/analogs & derivatives , Cardiotonic Agents/therapeutic use , Kinins/drug effects , Myocardial Infarction/prevention & control , Vasodilator Agents/therapeutic use , Acute Disease , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/drug effects , Bradykinin/therapeutic use , Chickens , Captopril/pharmacology , Disease Models, Animal , Ischemic Preconditioning, Myocardial , Kinins/blood , Kinins/physiology , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Preoperative Care , Vascular Resistance/drug effects
2.
Braz. j. med. biol. res ; 41(7): 557-562, July 2008. ilus, graf
Article in English | LILACS | ID: lil-489517

ABSTRACT

It is well known that the ventrolateral medulla contains neurons involved in the tonic and reflex control of the cardiovascular system. Two regions within the ventrolateral medulla were initially identified: the rostral ventrolateral medulla (RVLM) and the caudal ventrolateral medulla (CVLM). Activation of the RVLM raises arterial blood pressure and sympathetic nerve activity, and activation of the CVLM causes opposite effects. The RVLM premotor neurons project directly to sympathetic preganglionic neurons and are involved in the maintenance of resting sympathetic vasomotor tone. A significant proportion of tonic activity in the RVLM sympathetic premotor neurons is driven by neurons located in a third region of the ventrolateral medulla denominated caudal pressor area (CPA). The CPA is a pressor region located at the extreme caudal part of the ventrolateral medulla that appears to have an important role controlling the activity of RVLM neurons. In this brief review, we will address the importance of the ventrolateral medulla neurons for the generation of resting sympathetic tone related to arterial blood pressure control focusing on two regions, the RVLM and the CPA.


Subject(s)
Animals , Blood Pressure/physiology , Medulla Oblongata/physiology , Neurons/physiology , Vasomotor System/physiology , GABA Agents/pharmacology , Microinjections , Medulla Oblongata/drug effects , Neural Inhibition/physiology , Sympathetic Nervous System/physiology , gamma-Aminobutyric Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL